Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II TrialChunyan Lan, Xin Huang, Zhimin Liu et al.|Journal of Clinical Oncology|2020Cited by 217
The MYBL2–CCL2 axis promotes tumor progression and resistance to anti-PD-1 therapy in ovarian cancer by inducing immunosuppressive macrophagesBaoyue Pan, Min Zheng, Ting Wan et al.|Cancer Cell International|2023Cited by 29
The INSPECTOR study: enhanced feasibility for clinical translation of a multi‐cancer early detection method based on enzyme‐assisted high signal‐to‐noise ratio sequencing of methylated circulating tumor DNAHui Luo, Rui‐Hua Xu, Wei Wei et al.|癌症：英文版|2025Cited by 5
Apo10 and TKTL1 in blood macrophages as non-invasive biomarkers for early detection of cervical cancerShuqing Wang, Chuanbo Xie, Yuying Liu et al.|Cellular Oncology|2025Cited by 2
High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study.Hui Luo, Rui‐Hua Xu, Pansong Li et al.|Journal of Clinical Oncology|2024Cited by 1